Your browser doesn't support javascript.
loading
Rituximab in a risk-adapted treatment strategy gives excellent therapeutic results in nodular lymphocyte-predominant Hodgkin lymphoma.
Della Pepa, Roberta; Picardi, Marco; Giordano, Claudia; Zacheo, Irene; Pugliese, Novella; Cerchione, Claudio; Raimondo, Marta; Di Perna, Maria; Troncone, Giancarlo; Ciancia, Giuseppe; Intrieri, Mariano; Pane, Fabrizio.
Afiliação
  • Della Pepa R; Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy.
  • Picardi M; Department of Advanced Biomedical Science, Federico II University, Naples, Italy.
  • Giordano C; Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy.
  • Zacheo I; Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy.
  • Pugliese N; Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy.
  • Cerchione C; Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy.
  • Raimondo M; Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy.
  • Di Perna M; Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy.
  • Troncone G; Department of Advanced Biomedical Science, Federico II University, Naples, Italy.
  • Ciancia G; Department of Advanced Biomedical Science, Federico II University, Naples, Italy.
  • Intrieri M; Dipartimento di Medicina e Scienze per la Salute "V. Tiberio", Università degli studi del Molise, Campobasso, Italy.
  • Pane F; Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy.
Br J Haematol ; 182(5): 715-718, 2018 09.
Article em En | MEDLINE | ID: mdl-28737231

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Medição de Risco / Rituximab Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Medição de Risco / Rituximab Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article